SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-20-013152
Filing Date
2020-06-15
Accepted
2020-06-15 17:25:42
Documents
5
Period of Report
2020-06-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vxrt20200615_8k.htm 8-K 42264
2 EXHIBIT 10.1 ex_190534.htm EX-10.1 60954
3 EXHIBIT 10.2 ex_190535.htm EX-10.2 30607
4 EXHIBIT 99.1 ex_190537.htm EX-99.1 15174
5 ex_190537img001.jpg GRAPHIC 4260
  Complete submission text file 0001437749-20-013152.txt   156558
Mailing Address 385 OYSTER POINT BOULEVARD, SUITE 9A SOUTH SAN FRANCISCO CA 94080
Business Address 385 OYSTER POINT BOULEVARD, SUITE 9A SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 20964280
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences